TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmore Consulting AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
308
|
307 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
61
|
65 | |
| EBITDA |
61
|
65 | |
| Total assets |
86
|
87 | |
| Current assets |
80
|
81 | |
| Current liabilities |
26
|
27 | |
| Equity capital |
61
|
60 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
70.9%
|
69.0% | |
| Turnover per employee |
154
|
154 | |
| Profit as a percentage of turnover |
19.8%
|
21.2% | |
| Return on assets (ROA) |
70.9%
|
74.7% | |
| Current ratio |
307.7%
|
300% | |
| Return on equity (ROE) |
100%
|
108.3% | |
| Change turnover |
12
|
79 | |
| Change turnover % |
-3%
|
4%
|
35% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.